MAKINDO MEDICINEClinical textbook for medical students and doctors
For education and revision only. Not individual medical advice; check current NICE/BNF and local guidance before clinical use. Clinical safety and terms.
Chapter 290
MAKINDO MEDICINE · Biochemistry290

Clinical biochemistry: interpretation, test limitations and case mechanisms

Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.

Patterns of common biochemical tests

Test patternMechanismImportant caution
High ALT/ASTHepatocellular injury; AST also muscleALT/AST magnitude not direct measure of liver synthetic function
High ALP/GGTCholestasis or hepatobiliary enzyme inductionALP also bone/placenta; GGT supports hepatic source
High bilirubinHaemolysis, hepatocellular dysfunction or obstructionFractionate conjugated vs unconjugated
Raised troponinMyocardial injuryNot synonymous with type 1 MI; need ischaemic evidence and serial change
High CKSkeletal muscle injuryRhabdomyolysis risk depends also on kidney injury/electrolytes
Low albuminInflammation, dilution, low synthesis or lossPoor stand-alone nutritional marker
High lactateIncreased production or reduced clearanceCan occur without tissue hypoxia
Low sodiumExcess water relative to effective soluteExclude artefact and hyperglycaemia-associated shifts
High potassiumReduced excretion, redistribution or cell lysisRule out haemolysed sample, assess urgently if confirmed

Interpreting calcium and bone biochemistry

  • Total calcium is partly albumin bound; albumin-adjusted formulae are imperfect in critical illness and acid–base disturbance, so ionised calcium may be necessary.
  • Primary hyperparathyroidism often shows high calcium, inappropriately normal/high PTH, low-to-normal phosphate; malignancy-associated hypercalcaemia often suppresses PTH.
  • Renal failure can reduce calcitriol and increase phosphate, driving secondary hyperparathyroidism; chronic kidney disease mineral bone disorder is multifactorial.
  • Raised ALP with normal GGT may arise from bone turnover; inspect age, pregnancy, recent fracture and disease context.

Diabetes-related biochemistry and endocrinology

  • HbA1c represents haemoglobin glycation over erythrocyte lifespan; haemolysis, transfusion, haemoglobin variants, pregnancy or altered erythrocyte survival can make it misleading.
  • DKA is driven by insulin deficiency with lipolysis and hepatic ketogenesis; serum beta-hydroxybutyrate is particularly informative and urine acetoacetate may lag recovery.
  • Hyperosmolar hyperglycaemic state involves marked osmotic diuresis and dehydration with variable ketosis; evaluate effective osmolality and sodium correction.
  • Hypoglycaemia work-up can require paired glucose, insulin, C-peptide, proinsulin and sulfonylurea screen when appropriate and supervised.

Biochemical diagnostic reasoning

  • Start with pre-analytical effects: sample haemolysis, tourniquet duration, timing, recent meals, IV infusion contamination, circadian rhythm and medications.
  • Recognise physiological adaptation versus pathology: e.g., pregnancy changes ALP, volume status changes urea, strenuous exercise raises CK/AST.
  • Use trend and context rather than isolated numbers: sensitivity/specificity and reference interval depend on population and assay; a normal result never automatically excludes all disease.
  • For patient care consult current UK laboratory reference ranges, local protocols and up-to-date clinical guidance; this atlas is educational.
End of chapter 290